AU2002313690A1 - Five-membered heteroaromatic olefinic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of ncotinic cholinergic receptors - Google Patents
Five-membered heteroaromatic olefinic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of ncotinic cholinergic receptorsInfo
- Publication number
- AU2002313690A1 AU2002313690A1 AU2002313690A AU2002313690A AU2002313690A1 AU 2002313690 A1 AU2002313690 A1 AU 2002313690A1 AU 2002313690 A AU2002313690 A AU 2002313690A AU 2002313690 A AU2002313690 A AU 2002313690A AU 2002313690 A1 AU2002313690 A1 AU 2002313690A1
- Authority
- AU
- Australia
- Prior art keywords
- ncotinic
- olefinic
- inhibitors
- pharmaceutical compositions
- compositions containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2002/022997 WO2004009599A1 (en) | 2002-07-19 | 2002-07-19 | Five-membered heteroaromatic olefinic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of ncotinic cholinergic receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002313690A1 true AU2002313690A1 (en) | 2004-02-09 |
Family
ID=30769019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002313690A Abandoned AU2002313690A1 (en) | 2002-07-19 | 2002-07-19 | Five-membered heteroaromatic olefinic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of ncotinic cholinergic receptors |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002313690A1 (en) |
WO (1) | WO2004009599A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7192976B2 (en) | 2002-12-21 | 2007-03-20 | Angion Biomedica Corporation | Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
CN102149379A (en) | 2008-07-10 | 2011-08-10 | 安吉翁生物医药有限公司 | Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
AU2020272036A1 (en) | 2019-04-11 | 2021-11-04 | Angion Biomedica Corp. | Solid forms of (E)-3-[2-(2-thienyl)vinyl]-1H-pyrazole |
CN116178287A (en) * | 2023-02-21 | 2023-05-30 | 宁夏大学 | 3-phenylethynyl-1, 2, 4-triazole derivative and preparation method thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9226573D0 (en) * | 1992-12-21 | 1993-02-17 | Ici Plc | Heterocyclic compounds |
US5597919A (en) * | 1995-01-06 | 1997-01-28 | Dull; Gary M. | Pyrimidinyl or Pyridinyl alkenyl amine compounds |
ES2206571T3 (en) * | 1995-04-20 | 2004-05-16 | G.D. SEARLE & CO. | CYCLING AMIDINO AGENTS USED AS INHIBITORS OF NITRICO SINTASA OXIDE. |
AU6299496A (en) * | 1995-06-29 | 1997-01-30 | Novo Nordisk A/S | Novel substituted azabicyclic compounds |
AU5326100A (en) * | 1999-06-07 | 2000-12-28 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
WO2001016107A1 (en) * | 1999-08-31 | 2001-03-08 | Targacept, Inc. | Arylalkyloxyalkylamines and arylalkylthioalkylamines, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
JP2003513054A (en) * | 1999-11-01 | 2003-04-08 | ターガセプト,インコーポレイテッド | Aryl olefin and aryl acetylene azacyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of nicotinic cholinergic receptors |
US6624167B1 (en) * | 2000-08-04 | 2003-09-23 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
-
2002
- 2002-07-19 AU AU2002313690A patent/AU2002313690A1/en not_active Abandoned
- 2002-07-19 WO PCT/US2002/022997 patent/WO2004009599A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004009599A1 (en) | 2004-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL190218A0 (en) | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | |
HK1105864A1 (en) | Heterocyclic compounds which are active as inhibitors of beta-lactamases | |
HK1086485A1 (en) | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | |
IL174128A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
AU2003286711A1 (en) | Indazolinone compositions useful as kinase inhibitors | |
IL191960A0 (en) | Heterocyclic aromatic compounds and pharmaceutical compositions containing the same | |
WO2006034039A3 (en) | Substituted morphinans and methods of their use | |
IL174249A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
EP1613595A4 (en) | Novel compounds and compositions as protein kinase inhibitors | |
HUP0200804A3 (en) | The use of pharmaceutical compositions containing 4-h-1-benzopyran-4-one derivatives as inhibitors of smooth muscle cell proliferation | |
AU2003214335A1 (en) | Heterocyclic compounds which are active as inhibitors of beta lactamases | |
EP1673343A4 (en) | Compounds and compositions as protein kinase inhibitors | |
ZA200409862B (en) | Benzofused heteroaryl derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use | |
AU2003301302A1 (en) | Pyradazine compounds as gsk-3 inhibitors | |
WO2006126081A3 (en) | Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors | |
IL173930A0 (en) | Pharmaceutical compositions containing forms of r-baclofen | |
EP1670771A4 (en) | Compounds and compositions as protein kinase inhibitors | |
AU2003278393A1 (en) | New use for pharmaceutical composition | |
AU2003290734A1 (en) | Novel compounds as pharmaceutical agents | |
WO2004082623A3 (en) | Substituted piperidine compounds | |
AU2003292551A1 (en) | Pharmaceutical liquid composition containing pyridone derivative | |
IL173810A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
HUP0400193A3 (en) | Imidazolindion derivatives as metalloproteinase inhibitors, their use and pharmaceutical compositions containing them | |
AU2003269364A1 (en) | Use of piperazine derivatives as ccr1 antagonists | |
AU2003256922A1 (en) | Substituted heterocyclic compounds as modulators of the ccr5 receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |